Acorah Software Products - Accounts Production 15.0.400 false true false true No description of principal activity 27 February 2023 31 January 2024 31 January 2024 14692656 Ms C Smith iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14692656 2023-02-26 14692656 2024-01-31 14692656 2023-02-27 2024-01-31 14692656 frs-core:CurrentFinancialInstruments 2024-01-31 14692656 frs-bus:PrivateLimitedCompanyLtd 2023-02-27 2024-01-31 14692656 frs-bus:FilletedAccounts 2023-02-27 2024-01-31 14692656 frs-bus:Micro-entities 2023-02-27 2024-01-31 14692656 frs-bus:AuditExempt-NoAccountantsReport 2023-02-27 2024-01-31 14692656 frs-bus:Director1 2023-02-27 2024-01-31
Registered number: 14692656
E4 Health Ltd
Unaudited Financial Statements
For the Period 27 February 2023 to 31 January 2024
AM & Company
Balance Sheet
Registered number: 14692656
31 January 2024
£
Current assets 32,454
Creditors: Amounts Falling Due Within One Year (9,683 )
NET CURRENT ASSETS 22,771
TOTAL ASSETS LESS CURRENT LIABILITIES 22,771
Accruals and deferred income (900 )
NET ASSETS 21,871
CAPITAL AND RESERVES 21,871

Notes

1. General Information
E4 Health Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 14692656 . The registered office is 33 Waverley Avenue, London, E4 8HS.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
Page 0
Page 1
For the period ending 31 January 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Ms C Smith
Director
14/04/2024